Intervention to Support Partners and Informal Caregivers of Frail RA-patients
INSPIRE
Protocol for the Feasibility Study of INSPIRE: an Individually Tailored Support Intervention for Informal Caregivers of Older Adults With Rheumatoid Arthritis and Frailty
1 other identifier
interventional
25
1 country
1
Brief Summary
Background Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with pain, fatigue, functional limitations, and reduced quality of life. As more people live to older age with RA, age-related vulnerability such as frailty becomes increasingly relevant and may amplify functional decline, multimorbidity, and reliance on others. Informal caregivers (unpaid family members, friends, or neighbors) often provide substantial practical, emotional, and coordination support, yet caregiver needs are frequently overlooked in rheumatology care. INSPIRE (INtervention to Support Partners and Informal caREgivers of frail RA patients) is an individually tailored support intervention developed using the UK Medical Research Council framework for complex interventions and an iterative co-creation process involving older adults with RA and frailty, caregivers, healthcare professionals, and social care stakeholders. Before a definitive evaluation, feasibility and acceptability in routine care must be established. Aim To evaluate the feasibility and acceptability of delivering INSPIRE in routine rheumatology care and to test study procedures in preparation for a future definitive trial. Methods This is a single-arm feasibility study recruiting 25 informal caregivers of older adults with RA and frailty. Recruitment will occur within a fixed four-month window (1 March-1 July 2026) and will not be extended. Care recipients (older adults) will be ≥65 years with RA and frailty classified as Clinical Frailty Scale (CFS) 4-7. Caregivers will be ≥18 years, provide unpaid support, and report at least moderate burden defined as a Caregiver Burden Scale (CBS) mean score \>1.99 at screening. Participants will be recruited from Rigshospitalet (Center for Rheumatology and Spine Diseases) and rheumatology departments in Køge, Slagelse, and Holbæk. Identification uses routine patient-reported outcomes (DANBIO) with invitation of potentially frail patients (e.g., MDHAQ \>1.0) followed by telephone screening and CFS assessment; eligible patients nominate a caregiver who is then screened using CBS. Intervention INSPIRE is delivered by a trained healthcare professional over \~12 weeks and comprises three contacts: an initial consultation (60-90 min), a brief follow-up (15-30 min), and a final consultation (30-60 min). Content is tailored using a toolbox addressing validation of the caregiver role, emotional/practical support, education, communication, and navigation across health and municipal services. Involvement of the older adult in consultations is optional and based on preferences of both parties. Outcomes Feasibility outcomes include recruitment (screened/eligible/consented), retention at 12 weeks, questionnaire completeness, and deliverability (session completion, mode, duration). Acceptability will be assessed post-intervention using the Acceptability of Intervention Measure and supplemented by brief acceptability/feasibility questions and qualitative interviews. Fidelity and tailoring will be documented using structured session notes. Exploratory outcomes include caregiver burden measured by Caregiver burden scale, quality of life measured by WHOQOL-BREF (caregiver and older adult), and physical function measured by MDHAQ . Progression criteria Pre-specified criteria include approximately 50% recruitment of those approached, ≥85% retention, and high fidelity, reviewed using a trafficlight approach (go/amend/stop). Ethics and dissemination Written informed consent will be obtained from both the older adult and the caregiver prior to baseline data collection, with separate consent for any study components each participant takes part in (e.g., consultations, interviews). Findings will be disseminated through peer-reviewed publication, conferences, and stakeholder summaries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
March 17, 2026
March 1, 2026
10 months
January 22, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment rate
Recruitment rate will be assessed as the number of caregivers recruited out of the number of eligible caregivers
3 months
Retention rate
Retention rate will be assessed as the number of participants who withdrew from the study out of the total number of participants.
3 months
Intervention deliverability
Number of sessions completed
3 months
Intervention deliverability
Session duration
3 months
Intervention deliverability
Session mode
3 months
Secondary Outcomes (6)
Fidelity
3 months
Data completeness
3 months
Acceptability
3 months
Caregiver burden
Baseline and 3 months
Health related quality of life
Baseline and 3 months
- +1 more secondary outcomes
Study Arms (1)
Support intervention
EXPERIMENTALParticipants will receive the INSPIRE intervention
Interventions
Intervention: INSPIRE INSPIRE is delivered by a trained healthcare professional with rheumatology expertise and experience in psychosocial support and service navigation. The intervention runs over approximately twelve weeks and includes an initial consultation, follow-up, and a final consultation. The initial consultation (about 60-90 minutes) takes place at home or in the clinic and is guided by the caregiver's CBS pro-file. It focuses on recognizing and validating the caregiver role, identifying the most burdensome is-sues, exploring underlying causes, and establishing realistic goals. Based on the needs identified, the caregiver is introduced to a tailored toolbox of resources and referral pathways that may include emotional or psychological support options, guidance on managing practical and physical strain, support for social isolation, communication and relationship support, disease-related education, and assistance navigating municipal and health system services.
Eligibility Criteria
You may qualify if:
- Informal (unpaid) caregiver of an older adult with confirmed rheumatoid arthritis (RA)
- Aged ≥ 18 years
- Care recipient aged ≥ 65 years
- Able to provide informed consent
- Able to complete study questionnaires
- Reports at least moderate caregiver burden, defined as mean CBS score \> 1.99 at screening (Caregiver Burden Scale)
- Aged ≥ 65 years
- Confirmed diagnosis of RA
- Meets frailty eligibility in routine care, defined as Clinical Frailty Scale (CFS) ≥ 5
You may not qualify if:
- Severe cognitive impairment preventing participation
- Acute mental health crisis
- Other circumstances making it impracticable to complete the intervention and follow-up assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet, Center for Rheummatology and Spine Diseases
Glostrup Municipality, Capital Region, 2600, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bente Esbensen, Professor
Glostrup University Hospital, Copenhagen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 22, 2026
First Posted
March 2, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Data will be shared upon reasonable request